Sellam_2017_Arthritis.Res.Ther_19_11

Reference

Title : Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis -
Author(s) : Sellam J , Riviere E , Courties A , Rouzaire PO , Tolusso B , Vital EM , Emery P , Ferracioli G , Soubrier M , Ly B , Chavez HH , Taoufik Y , Dougados M , Mariette X
Ref : Arthritis Res Ther , 19 :11 , 2017
PubMedID: 28115013

Related information

Citations formats

Sellam J, Riviere E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferracioli G, Soubrier M, Ly B, Chavez HH, Taoufik Y, Dougados M, Mariette X (2017)
Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis
Arthritis Res Ther 19 :11

Sellam J, Riviere E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferracioli G, Soubrier M, Ly B, Chavez HH, Taoufik Y, Dougados M, Mariette X (2017)
Arthritis Res Ther 19 :11